SEATTLE - For the first time ever, there's a cancer treatment vaccine on the market, and a Seattle company is behind it. The biotech company Dendreon got approval Thursday from the Food and Drug ...

First comprehensive assessment of DNA errors that drive advanced prostate cancer SEATTLE - A team of researchers at Fred Hutchinson Cancer Research Center and the University of Washington has ...

Researchers have found long-term evidence that actively monitoring localized prostate cancer is a safe alternative to immediate surgery or radiation. The results, released Saturday, are encouraging ...

While Gary Pickering worked for a distribution company in San Diego, he began promoting a test that helps detect if a man has prostate cancer. Called the prostate specific antigen test, or PSA, it ...

Shares of Seattle-based Dendreon Corp. rose nearly 13 percent on Wednesday after the biotechnology company said it would file a federal application to market Provenge, its lead product designed to ...

SEATTLE – September 20, 2016 – Seattle Cancer Care Alliance (SCCA) has opened a new Prostate Cancer Genetics Clinic at their South Lake Union campus in Seattle. The specialty clinic will serve ...